Success Stories: NAILG Helps an MS/PhD Student in the Field of Computer Vision Secure an NIW Approval in Just a Month

Client’s Testimonial:

“I would like to sincerely thank you and your firm for your support throughout this entire process. Receiving the approval feels like accomplishing a major milestone, and I am truly delighted with the result. Now that I’ve received approval myself, I feel even more confident recommending your firm to more friends and fellow researchers, and I certainly will continue to do so. Thanks to your professional guidance, everything went smoothly without any major issues, and I deeply appreciate that. I look forward to continuing to work with you through to the final stage of this process.”

On April 12^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a MS/PhD Student in the Field of Computer Vision (Approval Notice).

General Field: Computer Vision

Position at the Time of Case Filing: MS/PhD Student

Country of Origin: South Korea

State of Residence at the Time of Filing: South Korea

Approval Notice Date: April 12^th, 2025

Processing Time: 1 month (Premium Processing Requested)

Case Summary:

With a strong academic background and significant research experience in artificial intelligence and computer vision, our client with a B.S. in electrical and computer engineering clearly demonstrates the qualifications necessary to contribute meaningfully to this evolving field. When the researcher approached North America Immigration Law Group for assistance with filing an I-140 NIW (National Interest Waiver) petition, we conducted a thorough evaluation of their academic and professional accomplishments. Confident in the merit of the case, we proceeded with representation and prepared a compelling petition.

We emphasized the following highlights in the NIW filing:

843 total citations, reflecting broad recognition of the researcher’s work by both dependent and independent scholars.
A publication record that includes 2 peer-reviewed journal articles, 5 peer-reviewed conference papers, 1 preprint, and 1 filed patent application—demonstrating both academic excellence and applied innovation.

The proposed endeavor focuses on developing cost-effective and high-performance AI systems to enhance visual data processing across key applications such as healthcare, autonomous driving, and manufacturing. The research addresses major challenges in continual learning, few-shot learning, and computational efficiency, supporting the development of scalable AI solutions for dynamic, real-world environments.

One expert testimonial further strengthened the case:

“Without a doubt, this researcher has advanced the field of computer vision through their unique ability to develop adaptive AI systems for dynamic environments, continual learning, and few-shot learning. Their success in mitigating catastrophic forgetting, improving learning efficiency under data constraints, and designing computationally efficient algorithms, combined with a solid publication record, makes it clear they are a leader in the field and an asset to the United States.”

Through a carefully structured petition, we demonstrated that the researcher’s technical expertise, scholarly impact, and innovation-driven approach uniquely position them to contribute to critical areas of U.S. industry and research.

We are proud to have supported this outstanding professional in securing NIW approval and look forward to the continued impact his work will have across multiple sectors. We thank him for choosing North America Immigration Law Group and wish him continued success in his career.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.